Literature DB >> 10807837

Phthisiology at the dawn of the new century.

M Lauzardo1, D Ashkin.   

Abstract

Tuberculosis (TB) has been and continues to be one of the most significant pathogens in terms of human morbidity and mortality. Although the resurgence of TB has been held in check in most developed countries, the epidemic rages on in most developing countries of the world. The specter of drug resistance is becoming a more credible challenge in many parts of the world, dimming the prospects of eventual elimination. However, great opportunities are arising as well, with an unprecedented focus on the global aspects of TB control. This article will review the status of TB today and put into perspective the prospects for its elimination in the coming century.

Entities:  

Mesh:

Year:  2000        PMID: 10807837     DOI: 10.1378/chest.117.5.1455

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Accuracy of bronchoalveolar lavage enzyme-linked immunospot assay to diagnose smear-negative tuberculosis: a meta-analysis.

Authors:  Zhenzhen Li; Wenzhe Qin; Lei Li; Qin Wu; Xuerong Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Tuberculosis at the beginning of the third millennium: one disease, three epidemics.

Authors:  P Van den Brande; F Vanhoenacker; M Demedts
Journal:  Eur Radiol       Date:  2003-08       Impact factor: 5.315

3.  Causes and predictive factors associated with "diagnosis changed" outcomes in patients notified as tuberculosis cases in a private tertiary hospital.

Authors:  Byung Ju Kang; Kyung-Wook Jo; Tai Sun Park; Jung-Wan Yoo; Sei Won Lee; Chang-Min Choi; Yeon-Mok Oh; Sang-Do Lee; Woo Sung Kim; Dong Soon Kim; Tae Sun Shim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-12-24

Review 4.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells.

Authors:  Sabrina Mariotti; Raffaela Teloni; Elisabetta Iona; Lanfranco Fattorini; Giulia Romagnoli; Maria Cristina Gagliardi; Graziella Orefici; Roberto Nisini
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Predictors of pulmonary involvement in patients with extra-pulmonary tuberculosis.

Authors:  Malak M El-Hazmi; Fawzia E Al-Otaibi
Journal:  J Family Community Med       Date:  2012-05

7.  The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

Authors:  Nicholas Ezati; Deus Lukoye; Eddie M Wampande; Kenneth Musisi; George W Kasule; Frank G J Cobelens; David P Kateete; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

8.  Diagnosis of tuberculosis in an Indian population by an indirect ELISA protocol based on detection of Antigen 85 complex: a prospective cohort study.

Authors:  Rajpal S Kashyap; Anju N Rajan; Sonali S Ramteke; Vijay S Agrawal; Sanjivani S Kelkar; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala
Journal:  BMC Infect Dis       Date:  2007-07-10       Impact factor: 3.090

9.  M. tuberculosis genotypic diversity and drug susceptibility pattern in HIV-infected and non-HIV-infected patients in northern Tanzania.

Authors:  Gibson S Kibiki; Bert Mulder; Wil M V Dolmans; Jessica L de Beer; Martin Boeree; Noel Sam; Dick van Soolingen; Christophe Sola; Adri G M van der Zanden
Journal:  BMC Microbiol       Date:  2007-05-31       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.